Roy Buchanan Stock Analyst Profile - JMP Securities Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Roy Buchanan

    Stock Analyst at JMP Securities

    (5)
    # 145
    Out of 5,506 analysts
    81
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Financial Services
    Top Industries:
    Biotechnology Drug Manufacturers - Specialty & Generic Asset Management

    19 Stocks

    Name Action PT Current % Upside Ratings Updated
    CDTX Cidara Therapeutics
    Maintains: Market Outperform
    153 173
    		101.99 69.62% 8 Oct 3, 2025
    ASMB Assembly Biosciences
    Initiates Coverage On: Market Outperform
    38
    		23.32 62.95% 1 Sep 24, 2025
    DVAX Dynavax Technologies
    Reiterates: Market Outperform
    32 32
    		10.1 216.83% 8 Aug 22, 2025
    ENTA Enanta Pharma
    Maintains: Market Outperform
    24 25
    		10.33 142.01% 15 Aug 12, 2025
    PYPD PolyPid
    Maintains: Market Outperform
    16 14
    		3.51 298.86% 2 Jun 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Outperform
    10 10
    		5.45 83.49% 9 May 28, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Outperform
    5 2
    		1.31 52.67% 9 May 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Outperform
    18 18
    		2.43 640.74% 3 Mar 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Perform
    n/a
    		n/a n/a 1 Feb 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Outperform
    7 4
    		3.3 21.21% 3 Feb 11, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Outperform
    23 14
    		1.55 803.23% 1 Jan 30, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Outperform
    33 33
    		83.92 -60.68% 1 Jan 10, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Outperform
    24 7
    		n/a n/a 2 Nov 21, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 5 Oct 1, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Outperform
    4 5
    		4.38 14.16% 5 Aug 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 3 Jul 18, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Outperform
    443 448
    		800 -44% 2 Mar 3, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Market Perform
    14 16
    		11.34 41.09% 1 Mar 1, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 2 Feb 16, 2023